Effects of Various Prophylactic Solutions on Postoperative Cytomegalovirus Infection in Liver Transplant Recipients

WANG Baoqing,ZHANG Jie,ZHANG Hanzhi,ZHOU Jian,HE Lixian

DOI: https://doi.org/10.3969/j.issn.1008-6358.2013.03.021

2013-01-01

Abstract:Objective:To investigate the status of postoperative cytomegalovirus(CMV) infection among the liver transplant recipients and to evaluate the effects of prophylactic solutions on CMV infection after liver transplantation in China.Methods:All the clinical and follow-up data was retrospectively investigated in 309 liver transplantation patients from January 2004 to March 2007 in Liver Transplantation Center,Zhongshan Hospital,Fudan university.Results: In the preoperative CMV-seropositive recipients,the CMV infection rates in the three prophylactic groups(PG group) who have been treated with intravenous ganciclovir(GCV),acyclovir(ACV),GCV+ACV were 10.5%,15.9% and 7.9%,respectively.The incidences of the CMV disease were 10.5%,8.3% and 3.2%,which showed significant differences compared to those in the non-prophylactic group(NPG group,42.3% and 15.4%,P<0.01).One-year overall survival rates of the three PG groups were 86.8%,78.0% and 88.9%,respectively.There was statistical difference in one-year survival rate between GCV+ACV group and the NPG group(P<0.05).Conclusions: In the preoperative CMV-seropositive recipients,all the three different prophylactic methods can lower the incidence of CMV infection and CMV disease.Moreover,GCV+ACV prophylactic treatment can significantly increase one-year survival rate of liver transplantation patients.